HealthEquity, Inc. HQY
| Analyste |
Entreprise |
Prix lors de l'analyse |
Prix cible |
Gain potentiel |
Date de publication |
| Scott Schoenhaus |
KeyBanc |
88.5 $ |
120 $ |
31.50 % |
08/10/2025 |
| Glen Santangelo |
Jefferies |
95.54 $ |
134 $ |
38.46 % |
03/09/2025 |
| Daniel Perlin |
RBC Capital |
88.7221 $ |
109 $ |
20.28 % |
28/08/2025 |
| Strong Buy |
Raymond James |
90.19 $ |
115 $ |
24.81 % |
25/03/2025 |
| Alexander Paris |
Barrington |
95.39 $ |
112 $ |
16.61 % |
10/12/2024 |
| George Hill |
Deutsche Bank |
82.66 $ |
103 $ |
20.34 % |
04/09/2024 |
| Stan Berenshteyn |
Wells Fargo |
84.74 $ |
110 $ |
25.26 % |
20/06/2024 |
| Scott Schoenhaus |
KeyBanc |
83.4 $ |
100 $ |
16.60 % |
04/06/2024 |
| Mark Marcon |
Robert W. Baird |
81.22 $ |
104 $ |
22.78 % |
04/06/2024 |
| Alexander Paris |
Barrington |
81.03 $ |
100 $ |
18.97 % |
03/06/2024 |
| Stan Berenshteyn |
Wells Fargo |
79.27 $ |
105 $ |
25.73 % |
07/05/2024 |
| Constantine Davides |
JMP Securities |
79.9 $ |
101 $ |
21.10 % |
04/04/2024 |
| Glen Santangelo |
Jefferies |
79.72 $ |
95 $ |
15.28 % |
28/03/2024 |
| Stephanie Davis |
Barclays |
81.36 $ |
104 $ |
22.64 % |
20/03/2024 |
| Sean Dodge |
RBC Capital |
81.36 $ |
92 $ |
10.64 % |
20/03/2024 |
| Mark Marcon |
Robert W. Baird |
70.97 $ |
87 $ |
16.03 % |
21/09/2023 |
| Scott Schoenhaus |
Loop Capital Markets |
65.67 $ |
85 $ |
19.33 % |
06/06/2023 |
| Charles Peters |
Raymond James |
40.24 $ |
70 $ |
29.76 % |
14/12/2021 |
| Scott Schoenhaus |
Stephens |
81.09 $ |
100 $ |
18.91 % |
01/07/2021 |
| Steven Halper |
Cantor Fitzgerald |
81.44 $ |
85 $ |
3.56 % |
08/06/2021 |